Q2 2024 Holdings
Filed 2024-08-13 | 4 holdings | $148.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Pharvaris N.V.(PHVS) | COM | N69605108 | $80.7M | 4,293,854 | 54.2% |
| Kura Oncology, Inc.(KURA) | COM | 50127T109 | $38.1M | 1,849,947 | 25.6% |
| Syndax Pharmaceuticals, Inc.(SNDX) | COM | 87164F105 | $18.0M | 875,000 | 12.1% |
| Lyell Immunopharma, Inc. | COM | 55083R104 | $12.1M | 8,325,000 | 8.1% |